Europe – Règlements européens relatifs aux dispositifs médicaux et de diagnostics in vitro :...
Le 10 juillet 2024, nous avons accueilli à Saint-Denis nos collègues européens dans le cadre d’un atelier de travail sur les dispositifs médicaux organisé...
Europe – Regulation (EU) 2024/1689 of the European Parliament and of the Council of...
The purpose of this Regulation is to improve the functioning of the internal market by laying down a uniform legal framework in particular for...
Europe – Regulation (EU) 2024/1860 of the European Parliament and of the Council of...
Regulations (EU) 2017/745 (3) and (EU) 2017/746 (4) of the European Parliament and of the Council establish a regulatory framework to ensure the smooth functioning of the internal market...
Europe – MDCG 2020-16 Rev.3 – Guidance on Classification Rules for in vitro Diagnostic...
This guidance, relating to the application of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) addresses the classification of in vitro diagnostic...
UK – Medical devices: UK approved bodies
Approved bodies under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) for medical devices...
Europe – MDCG 2021-5 Rev. 1 : Guidance on standardisation for medical devices
The EU legislative framework on medical devices currently consists of two Regulations adopted and entered into force in 2017:
• Regulation (EU) 2017/745 on medical...
Europe – MDCG 2024-10 Clinical evaluation of orphan medical devices
The level of clinical evidence that is required to place medical devices on the market has been increased by the MDR, including an increased...
Switzerland – Swissmedic prepares medtech industry for activation of medical devices database module
The first module of the swissdamed medical devices database goes online in August
Since the MRA with the EU has not been updated, Swissmedic does...
Europe – Health Technology Assessment : Guidance on reporting requirements for multiplicity issues and...
This guidance describes how to deal in practice with multiplicity issues and
complementary analyses (like specific subgroup analyses, specific post hoc analyses and sensitivity analyses)...
Europe – Health Technology Assessment : Guidance on outcomes for joint clinical assessments
Clinical outcome assessments (COAs), used in clinical studies (whether they are interventional (also called experimental), or observational), are a key component of health technology...